Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Clinical trial NCT03252431 · COMPLETED
Trial details
- NCT number
- NCT03252431
- Sponsor
- EVIVE Biotechnology
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2019-09-25
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.